
The diagnosis of osteoporosis is typically determined by bone mass density (BMD); however, bone turnover markers (BTMs) can provide information involving the bone remodeling process. A recent study found that BMD correlates negatively with BTM and positively with estradiol (E2) and magnesium (Mg(2+)) levels, and tartrate-resistant acid phosphatase-5b (TRAP-5b) demonstrates a specificity in identifying patients with postmenopausal osteoporosis.